medigraphic.com
Anales de la Sociedad Mexicana de Oftalmología y Archivos de la Asociación Para Evitar la Ceguera en México

2006, Number 2

<< Back Next >>

Rev Mex Oftalmol 2006; 80 (2)

Antecedente de hipertensión arterial sistémica en pacientes diabéticos con y sin retinopatía

Lima-Gómez V, Solorio-Smith R

Language: Spanish
References: 20
Page: 78-82
PDF size: 425.23 Kb.


ABSTRACT

Arterial hypertension (AH), a risk factor for developing diabetic retinopathy (DR), is present in up to 90% of Mexican diabetic population. Detecting DR could be associated to undiagnosed or irregularly controlled AH.
Aim: to identify whether AH history and blood pressure levels considered AH were more frequent in patients with DR than in diabetics without it.
Method: 63 patients with DR (group 1) and 63 without it (group 2) were randomly selected and paired by diabetes duration. Rates of AH history, systolic blood pressure (SBP) ›130 mmHg, diastolic blood pressure (DBP) ›80 mmHg and SBP, DBP and mean blood pressure (MBP) means were compared between groups.
Results: AH history rate was similar in both groups. SBP, DBP and MBP were higher in group 1. SBP ›130 mmHg was more frequent in group 1 (p= 0.001, OR 4.98), as well as DBP › 80 mmHg (p= 0.03, OR 2.18).
Conclusion: Although AH history did not differ between groups, DR was statistically associated to AH blood pressure levels, regardless of history. It is suggested that emphasis should be placed in achieving a tight control of blood pressure, besides metabolic control, in order to prevent DR progression.


REFERENCES

  1. Zuzuma I, Hata Y, Clermont A, Pokras A. Cyclic stretch and hypertension induce retinal expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2. potential mechanisms for Exacerbation of diabetic Retinopathy by Hypertension. Diabetes 2001; 50: 444-454.

  2. Gillow JT, Gibson JM, Dodson PM. Hypertension and diabetic retinopathy, what’s the story? Br J Ophthalmology 1999; 83:1083-1087.

  3. Lima-Gómez V, Rojas-Dosal JA, Aguilera-Cartas MC. Presentación de la retinopatía diabética en un hospital de población abierta Cir Ciruj 1999; 67:168-172.

  4. Lima-Gómez V, Rojas-Dosal JA. Estrategia de detección masiva de retinopatía diabética. El día “D” en el Hospital Juárez de México. Cir Ciruj 2000; 68:63-67.

  5. Lima-Gómez V. Oportunidad de detección temprana de retinopatía diabética mediante campañas de detección. Rev Hosp Jua Mex 2001; 68:4-7.

  6. Lima-Gómez V, Rojas-Dosal JA. Organización de campañas de detección de retinopatía diabética. Rev Mex Oftalmol 2001; 75:98-102.

  7. Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 1998; 105:1801-1815.

  8. Cruz-Corchado M. Panorama epidemiológico de la hipertensión arterial en México. Archivos de Cardiología de México. 2001; 71 (sup. 1):192-197.

  9. Donald F, Lloyd A. Clinical practical recommendations. Diabetic retinopathy. Diabetes Care 2003; 26(supl. 1):99-101.

  10. Shaughnessy A, Stawson D. What happened to the valid POEMS? A survey of review articles on treatment of Type 2 diabetes. BMJ 2003; 327:1-7.

  11. Moss SE, Klein R, Klein BE. The 14-year incidence of visual loss in a diabetic population. Ophthalmology 1998; 105:998-1003.

  12. Consenso Mexicano sobre el tratamiento integral del síndrome metabólico. Med Int Mex 2002; 18:12-41.

  13. Irwin RS, Rippe JS. Manual de cuidados intensivos. Marban Libros, 2002.

  14. Sowers J, Epstein M., Frohlich E. Diabetes, hypertension, and cardiovascular disease. Hypertension 2001; 1053-1059.

  15. Addison T. Pathophysiology of hypertension and endothelial dysfunction in patients with diabetes mellitus. Endocrinology and metabolism clinics. 2001; 30:1-14.

  16. Mc Farlane S, Kumar A. Sowers J. Mechanisms by which angiotensin-converting enzyme inhibitors prevents diabetes and cardiovascular disease. Am J Cardiol 2003; 91:1-10.

  17. Chase HP, Garg SK, Jackson WE, Thomas MA, Harris S, Marshall G. Blood pressure and retinopathy in type I diabetes. Ophthalmology 1993; 100:1133-1139.

  18. Marshall G, Garg SK, Jackson WE, Holmes DL, Chase HP. Factors influencing the onset and progression of diabetic retinopathy in subjects with insulin-dependent diabetes mellitus. Ophthalmology 1993; 100:862-867.

  19. Arend O, Rüffer M, Remky A. Macular circulation in patients with diabetes mellitus with and without arterial hypertension. Br J Ophtalmol 2000; 84:1392-1396.

  20. Cruickshanks KJ, Ritter LL, Klein R, Moss SE. The association of microalbuminuria with diabetic retinopathy. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Ophthalmology 1996; 103:1245-1249.




2020     |     www.medigraphic.com